This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Akimoto, T Articles by Sumida, T Search for Related Content PubMed PubMed Citation Articles by Akimoto, T Articles by Sumida, T Social Bookmarking                   What's this?

Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome

T Akama

Division of Rheumatology, Department of Internal Medicine, Institute of Clinical Medicine

I Kono

Department of Sports Medicine, Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba Science-city, Japan

T Sumida

Division of Rheumatology, Department of Internal Medicine, Institute of Clinical Medicine

Autoantibodies against prothrombin, including lupus anticoagulant antibodies (LAC), have been identified in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). To identify the epitopes of LAC in patients with SLE and APS, we analyzed B cell epitopes of anti-prothrombin Abs. Prothrombin was purified from fresh plasma samples from healthy subjects, and fragmented by thrombin. Two fragments (prethrombin-1, 50kDa, and fragment-i, 22 kDa) were separated and used for further experiments. The two fragments were coated on irradiated plate and the binding activities of sera from 13 patients with anti-prothrombin Abs (SLE, 7; APS, 4; SLE + APS, 2) were determined by using ELISA. The assay was conducted under the following conditions: use of irradiated plates, and TBS containing Tween-20. We detected two types of anti-prothrombin Abs. The first was anti-prethrombin-l (n = 5) while the other was Ab against fragment-I (n = 8). There were no patients with Abs that showed binding activities to both fragments. A higher proportion of patients with thrombosis were positive for anti-prethrombin-I Abs (80%) than for anti-fragment-I Abs (25%). Two patients with anti-prethrombin-I Ab were positive for LAC and negative for anti-cardiolipin-f3₂ glycoprotein I antibody (aCL-I3₂GPI). Our results strongly support the notion that both prethrombin-I and fragment-1 on prothrombin molecule are B cell epitopes.

Key Words: antiphospholipid antibodies • antiphospholipid syndrome • prothrombin • systemic lupus erythematosus

Lupus, Vol. 8, No. 9, 761-766 (1999)
DOI: 10.1191/096120399678840963


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Horita, K. Ichikawa, H. Kataoka, S. Yasuda, T. Atsumi, and T. Koike Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies Lupus, July 1, 2007; 16(7): 509 - 516. [Abstract] [PDF]

				K Yoshida, A Tsutsumi, Y Ohnishi, T Akimoto, H Murata, and T Sumida T cell epitopes of prothrombin in patients with antiphospholipid syndrome Ann Rheum Dis, September 1, 2003; 62(9): 905 - 906. [Full Text] [PDF]